STAGE IV GALLBLADDER CANCER AJCC V8
Clinical trials for STAGE IV GALLBLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV GALLBLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV GALLBLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple attack on tough tumors: drug combo plus radiation shows promise
Disease control OngoingThis study tests a combination of two drugs (peposertib and avelumab) plus a special type of radiation for people with advanced solid tumors or bile duct cancers that have spread. The goal is to find the best dose and see if the treatment can shrink tumors or stop them from growi…
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Targeted combo shows promise for tough biliary cancers
Disease control OngoingThis study tests whether adding the targeted drug binimetinib to standard chemotherapy (FOLFOX) can shrink tumors or help people with advanced biliary tract cancers live longer. It is for patients whose cancers have specific MAPK gene changes and have already tried one prior trea…
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC